## NDAQ: Nasdaq, Inc. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_10 -0.1% below STRENGTH zone (3.0-6.0%); PEG 1.52 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.5% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($93.72)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. FibroBiologics receives Nasdaq delisting notice, requests hearing to appeal**
- Source: Investing.com | 20260102T231157 | Somewhat-Bearish | Relevance: 73%
- FibroBiologics, Inc. (NASDAQ:FBLG) announced it received a Nasdaq delisting notice for non-compliance with the minimum bid price requirement. The company plans to request a hearing to appeal the decision and has filed proxy materials for a reverse stock split to regain compliance. This news follows recent advancements like an IND filing for a psoriasis therapy and a successful direct offering to raise capital.

**2. Guarantor: JPMorgan Chase & Co.**
- Source: StreetInsider | 20260102T181036 | Neutral | Relevance: 64%
- JPMorgan Chase Financial Company LLC, guaranteed by JPMorgan Chase & Co., is offering Uncapped Accelerated Barrier Notes linked to the Nasdaq-100, Russell 2000, and S&P 500 Indices. These notes offer an uncapped return of at least 1.58 times the appreciation of the least performing index at maturity. Investors risk losing part or all of their principal, as the notes do not guarantee principal return and are subject to the credit risks of both JPMorgan Financial and JPMorgan Chase & Co.

**3. Who Owns MSCI? Top Shareholders and Recent Insider Trades**
- Source: TIKR.com | 20260101T120846 | Somewhat-Bullish | Relevance: 64%
- This article details the top shareholders of MSCI Inc. (NYSE: MSCI), a leading provider of equity indexes and risk tools. It highlights that MSCI's ownership is primarily institutional, with large passive investors providing stability, while active managers show mixed views on valuation. Additionally, the article reviews recent insider trades, noting balanced activity that doesn't suggest a strong directional signal for the stock.

**4. OLD National Bancorp IN Has $172.92 Million Position in Microsoft Corporation $MSFT**
- Source: MarketBeat | 20260101T111246 | Neutral | Relevance: 63%
- OLD National Bancorp IN increased its stake in Microsoft Corporation by 0.5% in the third quarter, making Microsoft its fifth-largest holding worth $172.92 million. Institutional investors collectively own 71.13% of Microsoft's stock, with other hedge funds also adjusting their positions. The article also covers Microsoft's recent price performance, earnings, dividend announcement, analyst ratings, trending headlines, and insider activity.

**5. Who Owns Equifax? Top Shareholders and Recent Insider Trades**
- Source: TIKR.com | 20260102T000834 | Neutral | Relevance: 63%
- This article details the major shareholders of Equifax (NYSE: EFX), highlighting large institutional investors like The Vanguard Group and BlackRock, and their recent trading activities. It also examines recent insider trades, primarily sales, to provide insight into how company leaders and major investors are positioning themselves with regard to Equifax shares. The combined data suggests stable institutional support but a mixed view on valuation among active managers and cautious insider selling.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-22 | Morgan Stanley | $111 | $110 | +1% |
| 2025-12-12 | Barclays | $114 | $109 | +5% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-22 | Morgan Stanley | main | Overweight |
| 2025-12-12 | Barclays | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 5 ($2.65M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 49.0% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 5 |

**Top Holders:**
- Vanguard Group Inc: 10.4% (+6.9%)
- Investor AB: 10.2% (0.0%)
- Blackrock Inc.: 7.0% (+8.3%)
- Wellington Managemen: 7.0% (-3.5%)
- Massachusetts Financ: 4.6% (-3.3%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.52 elevated, pricing in significant growth expectations. Forward P/E 25.3x stretched relative to 11% growth. Quality metrics strong (margin 20%). Insider selling cluster ($2.7M in 90 days), potential headwind. Institutional flow bearish (5 selling vs 4 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $55.5B |
| Beta | 1.02 |
| 52W Range | $64.84 - $99.59 |
| Short Interest | 1.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.52 |
| Forward P/E | 25.3 |
| Current P/E | 28.2 |
| YoY Growth | 11.5% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 2.4% to -0.1% (-2.5% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.1pp (needs >3.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). OFD pattern: -SLN (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.14% (CS: 33) | Neutral |
| RSI_14 | 62.4 | Neutral |
| MACD Histogram | 0.07 | Bullish |
| vs SMA20 | 1.021x | Above |
| vs SMA50 | 1.069x | Above |
| vs SMA200 | 1.110x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $96.66
- **Stop Loss:** $93.72 (3.0% risk)
- **Target:** $99.60 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 489
- **Position Value:** $47,266.74
- **Portfolio %:** 47.27%
- **Risk Dollars:** $1,440.00
- **Risk Per Trade:** 1.44%
- **Modifiers:** L1 120% | L2 120% | Combined 1.44x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.20x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with stable risk appetite as 2026 trading begins. VIX at 14.51 (4th percentile) signals complacency while positive yield curve (+65bps) and moderate breadth (53.1%) support continuation. Focus on upcoming jobs data (Jan 9) and earnings season kickoff mid-January for directional catalysts.*

### Earnings

**Next:** 2026-01-28 (Est: $0.91)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.85 | $0.88 | +3.7% |
| 2025Q2 | $0.81 | $0.85 | +4.6% |
| 2025Q1 | $0.77 | $0.79 | +2.5% |
| 2024Q4 | $0.75 | $0.76 | +1.4% |

---
*RULE-based L3 | 2026-01-06 17:52 | MRS_10*